AC Immune SA (ACIU)

NASDAQ: ACIU · IEX Real-Time Price · USD

5.00

+0.16 (3.31%)

At close: Dec 29, 2023, 4:00 PM

5.07

+0.07 (1.40%)

After-hours: Dec 29, 2023, 7:23 PM EST

Income Statement (Annual)

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	3.94	0	15.43	110.46	6.91	20.26	23.21	39.09	30.27
Revenue Growth (YoY)	-	-	-86.03%	1498.03%	-65.88%	-12.75%	-40.61%	29.14%	-
Gross Profit	3.94	0	15.43	110.46	6.91	20.26	23.21	39.09	30.27
Selling, General & Admin	15.79	17.91	18.56	16.06	12.47	10.13	7.9	3.42	3.44
Research & Development	60.34	62.28	59.49	50.43	44.28	32.66	25.77	17.05	16.12
Other Operating Expenses	-1.34	-1.18	-1.35	-0.57	-0.28	0	0	0	0
Operating Expenses	74.78	79.01	76.69	65.92	56.46	42.79	33.67	20.47	19.55
Operating Income	-70.85	-79.01	-61.26	44.54	-49.55	-22.54	-10.46	18.62	10.72
Interest Expense / Income	0.36	0.58	0.18	1.93	0.33	0.15	0.01	0	0
Other Expense / Income	-0.46	-6.6	0.48	-2.83	1.07	3.73	-3.37	-1.65	-0.03
Pretax Income	-70.74	-72.99	-61.92	45.44	-50.95	-26.41	-7.1	20.27	10.74
Income Tax	0.01	0	0	0	0	0	0	0	0
Net Income	-70.75	-73	-61.92	45.44	-50.95	-26.41	-7.1	20.27	10.74
Net Income Growth	-	-	-	-	-	-	-	88.66%	-
Shares Outstanding (Basic)	84	73	72	68	57	57	50	43	43
Shares Outstanding (Diluted)	-	-	-	-	-	57	50	46	46
Shares Change	15.88%	1.43%	6.36%	17.80%	0.47%	13.95%	8.80%	1.08%	-
EPS (Basic)	-0.85	-0.97	-0.86	0.64	-0.82	-0.46	-0.14	0.47	0.25
EPS (Diluted)	-0.85	-0.97	-0.86	0.64	-0.82	-0.46	-0.14	0.44	0.24
EPS Growth	-	-	-	-	-	-	-	83.33%	-
Free Cash Flow	-74.4	-67.85	-60.89	53.34	-45.63	-24.07	-6.46	43.79	-17.77
Free Cash Flow Per Share	-0.88	-0.93	-0.85	0.79	-0.80	-0.42	-0.13	1.01	-0.42
Gross Margin	100.00%	-	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-1800.43%	-	-396.99%	40.32%	-716.87%	-111.28%	-45.04%	47.64%	35.41%
Profit Margin	-1798.04%	-	-401.28%	41.14%	-737.14%	-130.39%	-30.57%	51.85%	35.50%
Free Cash Flow Margin	-1890.67%	-	-394.59%	48.29%	-660.16%	-118.85%	-27.84%	112.03%	-58.70%
EBITDA	-68.03	-70.01	-59.77	49.06	-49.66	-25.68	-6.81	20.56	11.05
EBITDA Margin	-1728.74%	-	-387.34%	44.42%	-718.40%	-126.80%	-29.34%	52.59%	36.49%
Depreciation & Amortization	2.36	2.41	1.97	1.69	0.96	0.58	0.28	0.29	0.3
EBIT	-70.39	-72.41	-61.74	47.37	-50.62	-26.26	-7.09	20.27	10.75
EBIT Margin	-1788.69%	-	-400.08%	42.88%	-732.31%	-129.67%	-30.54%	51.85%	35.51%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).